Incline Therapeutics, Inc. — Form D
Incline Therapeutics, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-09-27. The offering totals $21.5M, of which $21.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-09-27
- Form: D
- Accession: 0001481336-11-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $21.5M
- Amount sold: $21.5M
- Minimum investment: $5K
- Investors: 15
- Date of first sale: 2011-09-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-166453
Issuer
- Name: Incline Therapeutics, Inc.
- CIK: 0001481336
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 900 SAGINAW DRIVE, SUITE 200, REDWOOD CITY, CA, 94063
- Phone: (650) 241-6800
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| James Glasheen, Ph.D. | Director | Palo Alto, CA |
| TERRY GOULD | Director | NESS ZIONA, L3 |
| ALAN LEVY, PH.D. | Director | HAYWARD, CA |
| Theodore R Schroeder | Director | San Diego, CA |
| James Topper, M.D., Ph.D. | Director | Menlo Park, CA |
| James W Young, Ph.D. | Director | Menlo Park, CA |
| ALAN LEVY, PH.D. | Executive Officer | HAYWARD, CA |
| David A Socks | Executive Officer | Indianapolis, IN |
| James Topper | Director | La Jolla, CA |
| Jim Young | Director | San Francisco, CA |
| Jim Glasheen | Director | San Diego, CA |
| David Socks | Executive Officer | Menlo Park, CA |
Other filings by this issuer (2)
More